Skip to content
10-Q

Quarterly Report

NP Life Sciences Health Industry Group Inc. ACAT

0001493152-23-028270

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 14, 2023 42.96M sh
Shares Diluted Q2 2023 · Jun 30, 2023 42.96M sh
Shares Diluted Q2 2023 · Jun 30, 2023 42.96M sh
Shares Diluted Q2 2023 · Jun 30, 2022 42.96M sh
Shares Diluted Q2 2023 · Jun 30, 2022 42.96M sh
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$19.11K
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$27.41K
Cash And Equivalents Q2 2023 · Jun 30, 2023 $125.11K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $121.86K
Stockholders Equity Q2 2023 · Jun 30, 2023 $67.11K
Stockholders Equity Q2 2023 · Dec 31, 2022 $19.32K
Stockholders Equity Q2 2023 · Jun 30, 2022 $8.16K
Stockholders Equity Q2 2023 · Dec 31, 2021 $38.17K
Total Liabilities Q2 2023 · Jun 30, 2023 $77K
Total Liabilities Q2 2023 · Dec 31, 2022 $108.47K
Total Assets Q2 2023 · Jun 30, 2023 $144.11K
Total Assets Q2 2023 · Dec 31, 2022 $127.78K
Sga Expense Q2 2023 · Jun 30, 2023 $35.71K
Sga Expense Q2 2023 · Jun 30, 2023 $64.48K
Sga Expense Q2 2023 · Jun 30, 2022 $13.91K
Sga Expense Q2 2023 · Jun 30, 2022 $45K
Net Income Q2 2023 · Jun 30, 2023 $71.2K
Net Income Q2 2023 · Jun 30, 2023 $47.8K
Net Income Q2 2023 · Jun 30, 2022 $1.08K
Net Income Q2 2023 · Jun 30, 2022 −$30.01K
Operating Income Q2 2023 · Jun 30, 2023 $71.39K
Operating Income Q2 2023 · Jun 30, 2023 $72.62K
Operating Income Q2 2023 · Jun 30, 2022 $1.08K
Operating Income Q2 2023 · Jun 30, 2022 −$30.02K
Revenue Q2 2023 · Jun 30, 2023 $107.1K
Revenue Q2 2023 · Jun 30, 2023 $137.1K
Revenue Q2 2023 · Jun 30, 2022 $14.98K
Revenue Q2 2023 · Jun 30, 2022 $14.98K